MCAM and cancer: In recent years, various investigations revealed that CD146 overexpression significantly relates with the metastasis, progression and formation of new blood vessels of some malignant tumors which was investigated in melanoma, esophageal cancer, prostate cancer, gallbladder adenocarcinoma, ovarian carcinoma [87, 88, 92–101].